| Overview |
| bsm-52028m |
| Cdk4 (2F6) Monoclonal Antibody |
| WB, IHC-P, IHC-F, IF, ICC/IF |
| Human |
| Specifications |
| Unconjugated |
| Mouse |
| Recombinant human Cdk4 protein, around C-terminal 101aa. |
| Monoclonal |
| #REF! |
| IgG2c |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 1019 |
| P11802 |
| Cyclin-dependent kinase 4; CDK4; Cell division protein kinase 4; PSK-J3 |
| Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex. |
| Application Dilution |
| WB |
=1:500-2000 |
| IHC-P |
IHC-P=1:50-200 |
| IHC-F |
IHC-F=1:50-200 |
| IF |
IF=1:50-200 |
| ICC/IF |
ICC/IF=1:50-200 |